Central Monitoring Summit Philadelphia, Pennsylvania, USA 22-23 March 2018

Description:
Successfully introducing new drugs and therapies in a quicker and more cost-effective manner starts in the most complex phase on of drug development; the clinical phase. The implementation of risk-based monitoring increases the overall quality of data while providing better oversight of patient safety. With the introduction of centralized monitoring in a risk-based monitoring approach, pharmaceutical companies are able to embrace a real-time overview of data and risk detection.

The Central Monitoring Summit will arm delegates with the tools they need to optimize existing clinical operation platforms and build quality into the design for a sound central monitoring foundation. Join your colleagues and our expert speaking staff as they provide in-depth insights into shifting your monitoring processes from an excessive concentration of data to risk-driven monitoring that uses central monitoring and technology enablement.

Prices:
Early Bird Pricing - Register by February 2, 2018: USD 1895
Standard Pricing - Register after February 2, 2018: USD 2095
Onsite Pricing: USD 2195

Speakers: Anne M. Smith, Elizabeth Robinson, Kimberly Nessel, Jaylaxmi Nalawade, Joanne Benedict, Lisa Berdan, David Bocobo, Sina Djali, Oksana Gecha, Jennessa Martin

Time: 8:00 am to 5:00 pm